Mayo Clinic exec to lead Fitzsimons Redevelopment Authority (via Denver Business Journal)
Aurora, CO, March 14, 2012 - Following an extensive national search, Fitzsimons Redevelopment Authority (FRA) has named
Steve VanNurden as its new President and Chief Executive Officer, beginning in late May. The announcement is made by John
M. Shaw, Chair of the FRA Board of Directors, who said: "Steve, a seasoned leader in the life science/bioscience space,
comes to us from Mayo Clinic in Rochester, Minnesota."
The appointment of Mr. VanNurden is further evidence
of the FRA's continued commitment to support the development of life science companies in Colorado in partnership with the
State’s research institutions. He will be working with universities, local economic development agencies, state and
local governments, and the bioscience industry to promote the successful development of the 180 acre Colorado Science + Technology
Park, which is adjacent to the University of Colorado’s Anschutz Medical Campus in Aurora.
Steve Hogan, Mayor
of the City of Aurora and FRA Board member stated, “Steve is the partner we need to fulfill the promise of the bioscience
industry park. His working relationships span nationally and internationally, which will be a great advantage for us.”
Steve VanNurden is currently Chair of Mayo Clinic Ventures, the invention arm for Mayo Clinic. Under Mr. VanNurden’s
direction, this division is responsible for patenting and commercializing Mayo’s discoveries, inventions and other intellectual
property. Since 1986, Mayo Clinic Ventures has successfully commercialized over 2,000 technologies and has been granted more
than 1,200 patents. Under the guidance of Mr. VanNurden, Mayo’s technology based ventures efforts have paid off, resulting
in the formation of 45+ Mayo Clinic start-up companies.